// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Drug coated balloon only angioplasty for stemi

Ioannis Merinopoulos - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Long term clinical outcomes following percutaneous coronary intervention to saphenous venous graft in acute coronary syndrome

Maria Zakai - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Outcome of stemi patients admitted through inter hospital transfer vs direct admission to ppci centre

Tarek Abdeldayem - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiogenic shock

N/A

Swindon heart attack program to evaluate and improve timing of angiography in nstemi shape it nstemi

Tom Hyde - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Nurse led sedation is safe and effective shortening procedure times and improving access for selected transcatheter aortic valve implantation tavi patients

Suzannah Browne - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Oxygen uptake efficiency slope a valuable substitute for peak vo2

Amelia Rudd - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Preventing stroke in patients with atrial fibrillation and intracerebral haemorrhage a qualitative study of physicians decision making

Elena Ivany - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Hydroxyzine

Qualitative study on influences on anticoagulant prescribing for stroke prevention in atrial fibrillation

Rawand Jarrar - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Warfarin

The utility and educational impact of a virtual webinar to deliver an international undergraduate cardiovascular conference

Sashiananthan Ganesananthan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Meeting in the metaverse a new paradigm for scientific mentorship

Danny Radford - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bariatric surgery reverses ventricular repolarisation heterogeneity mechanistic insights into fat related arrhythmic risk

Kiran Patel - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Determinants of post operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the statin therapy in cardiac surgery stics trial

Rohan Wijesurendra - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

ILS-969

Variants of uncertain significance a real world experience of reclassification from the inherited arrhythmia clinic

Soe Maung - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Cardiac resynchronisation therapy acutely alters metabolic substrate uptake correlating with improvements in systolic function and long term reverse remodelling

Peregrine Green - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Dextrose Intravenous

Long term clinical outcomes in patients requiring cardiac pacing due to congenital complete heart block

Sam Seitler - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital complete heart block

N/A

Crt upgrade is safe can be achieved in 99 of cases and is associated with an improvement in left ventricular function in more than half of patients

Stewart Brown - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can lesion parameters predict effective pulmonary vein isolation in very high power short duration radiofrequency ablation

Akash Mavilakandy - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adenosine

Longterm follow up of myotonic dystrophy type 1 patients with pacemaker and implantable cardioverter defibrillators a single uk specialist centre experience

yuran zheng - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Myotonic dystrophy

N/A

Atrial fibrillation virtual ward a glimpse into the future of af care

Ahmed Kotb - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Novel ambulatory electrocardiogram ecg devices for the investigation of palpitations pre syncope and syncope a local nhs joint working quality improvement project

Wai Yan Kyaw Nyunt Thinn - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Syncope

N/A

Copyright © 2026. QuantiNova All rights reserved